| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | — | |||||||||||||
| Cost of revenues | ||||||||||||||
| Gross profit | ||||||||||||||
| % of revenue | 38.9% | — | ||||||||||||
| Research and development expenses | ||||||||||||||
| General and administrative expenses | ||||||||||||||
| Operating loss | ||||||||||||||
| % of revenue | -622.8% | — | ||||||||||||
| Financing income (expenses), net | ||||||||||||||
| Other loss | — | — | ||||||||||||
| Net loss | ||||||||||||||
| % of revenue | -487.2% | — | ||||||||||||
| Loss per share (basic) (in Dollars per share) | ||||||||||||||
| Loss per share (diluted) (in Dollars per share) |